Deutsch

enlarged text

ABOUT LUX

Lux Biosciences is a clinical stage biotechnology company specialized in the field of ophthalmic diseases. We are developing novel medications to treat the underlying causes of ophthalmic diseases and alleviate their symptoms, and if approved by regulatory authorities, we plan to commercialize these products. With two first-in-class products currently in Phase 3 clinical development and several innovative, highly promising earlier stage projects, we have made significant progress towards building a revenue-generating, high-growth and sustainable ophthalmic company.